Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 4,166 shares at $36.17 ($151K) on 2020-09-08, disclosed to the SEC on 2020-09-09.
Open-market sale of $151k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.17 | 2,083 | $75K | 50.0% |
| 2 | $36.17 | 2,083 | $75K | 50.0% |
| Total | $36.17 avg | 4,166 | $151K | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |